Inventor · disambiguated record
Hua Gong
Also filed as: GONG HUA · GONG HUA CHANG
16 granted patents·6 pending applications·18 citations·filing 2007–2022
87Inventor score
Top patents by PatentIndex Score
22 records- 0187US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0287US8114616B2Methods for diagnosing irritable bowel syndromeGONG HUA·Filed 2010·Granted Feb 14, 2012·7 cites·10 claims
- 0380US8709733B2Methods for diagnosing irritable bowel syndromeGONG HUA·Filed 2012·Granted Apr 29, 2014·3 cites·9 claims
- 0480US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 0575US10023576B2Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·2 cites·10 claims
- 0673US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 0755US9482672B2Methods for diagnosing irritable bowel syndromeNESTEC SA·Filed 2014·Granted Nov 1, 2016·0 cites·21 claims
- 0855US2024262806A1Inhibitors of nlrp3PTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0954US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 1054US2024209091A1Methods for treating cancer using anti-ctla4 antibodiesADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 1152US12492200B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Dec 9, 2025·0 cites·12 claims
- 1251US12187706B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 1350US12338228B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jun 24, 2025·0 cites·12 claims
- 1450US12150937B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Nov 26, 2024·0 cites·16 claims
- 1546US9663469B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·0 cites·6 claims
- 1646US9593113B2Imide and acylurea derivatives as modulators of the glucocorticoid receptorBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 14, 2017·0 cites·15 claims
- 1746US2014057798A1Prediction of drug sensitivity of lung tumors based on molecular genetic signaturesNESTEC SA·Filed 2013·Application pending·0 cites
- 1845US9725443B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 8, 2017·0 cites·2 claims
- 1944US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 2041US2012315630A1Methods for diagnosing irritable bowel syndromeGONG HUA·Filed 2012·Application pending·0 cites
- 2140US2017081475A1Method for preparing ployesteramides by organic cataliysisNANJING UNIVERSITY OF TECHNOLOGY·Filed 2016·Application pending·0 cites
- 2239US2013005596A1Novel genomic biomarkers for irritable bowel syndrome diagnosisNESTEC SA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hua Gong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →